Remote Eczema
Research Study
Eczema (atopic dermatitis) is a common skin condition that causes itching, dryness, and inflammation, and current treatments don’t work well for everyone. Researchers are exploring whether helpful skin bacteria and natural ingredients can improve symptoms and provide longer-lasting relief. This study will examine whether a topical probiotic (Roseomonas mucosa) with cardamom can reduce eczema symptoms and itch, and whether these benefits continue after treatment stops.
Fast Facts
Diagnosed with eczema
Have eczema on their face, folds of elbows, or back of knees
Compensation
up to $190
Conducted
remotely
Additional Information
This study is being conducted to better understand eczema (atopic dermatitis) and to explore ways to improve symptoms, reduce itching, and provide longer-lasting relief using a topical probiotic and natural treatment.
You may be eligible for this study if you meet the following criteria:
- Age 2 years or older
- Diagnosed with eczema (atopoic dermatitits)
- Have not started any new medicaitons in the past month
- Willing to participate in virtual visits every 7 weeks over a 28 week period
- Willing to avoid starting new medications during the study
- Do not have a suspected or known immune system disorder
- Not currently pregnant or breastfeeding, or planning to become pregnant
- Have not started certain eczema-related treatments within the past 3 months (unless stable for at least 3 months).
Overall Duration
This study lasts about 28 weeks (around 7 months). It includes 14 weeks of using the study product, followed by 14 weeks of follow-up.
In-Lab Activities (All Virtual)
All visits are done online—no in-person visits are required.
- You will have a screening visit where the study team explains the study and reviews consent.
- Once you receive your study materials by mail, you will have a baseline visit. During this visit, you will be guided through a simple, non-invasive skin swab to collect a sample from your skin.
- You will also complete a detailed survey about your health, diet, and home environment.
- Virtual check-in visits will take place every 7 weeks to monitor your progress.
- Short surveys will be sent about every 3–4 weeks to track your symptoms and response to the study product.
- No video or audio recordings are required beyond standard virtual visit communication.
At-Home Activities
- You (or your child) will apply a topical spray (either the study product or a placebo) to the skin 2–3 times per week for 14 weeks.
- You will complete short online surveys about symptoms, itching, and general health every few weeks.
- After 14 weeks, you will stop using the product but continue completing surveys and attending virtual check-ins for another 14 weeks.
- The study collects information about your symptoms and skin bacteria, but does not track unrelated personal data.
Participants may receive up to $190 for their time and participation in this fully remote study. All study materials are shipped directly to your home, so no travel or transportation is needed. Participants will also receive a free skin microbiome assessment and have virtual consultations with NIH study providers as part of the study.
There is no cost for you to participate in our research study.